MEA Parenteral Nutrition Market Analysis By Type of Nutrition (Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals), By Dosage Form, By Region, And Segment Forecasts, 2018 - 2025

Report Overview

The Middle East and Africa parenteral nutrition market size was valued at USD 203.6 million in 2016 and is expected to grow at a CAGR of 7.1% over the forecast period. Increasing natality rate, rising number of premature births, risk of malnutrition, and increasing prevalence of chronic disorders such as cancer are the key growth rendering drivers responsible for the lucrative growth of the market.

Saudi Arabia parenteral nutrition market, by type of nutrition, 2014 - 2025 (USD Million)

The natality rate indicates the total number of births per 1,000 people and is useful to understand the rise in the population of a region. Growth in population increases the burden of healthcare costs and food expenditure for a household as well as the nation. Thus, a higher birth rate is expected to impact the nutrition level, thereby acting as a driver for the market.

Most of the premature babies suffer from low weight and undeveloped immunity, which puts them at risk. These formulations diminish the risk of infection and underdevelopment, thus promoting its application. The demand for parenteral nutrition is higher in very low birth weight (VLBW) newborns due to the low prospect of enteral nutrition. Use of these formulations in premature infants leads to faster neurological development, improved intrauterine nutrient deposition, and minimized risk of complications, thereby improving their chances for survival. 

Malnutrition is one of the major drivers of the market. According to the UNICEF, malnourishment in the first 1,000 days of an infant’s life may lead to impaired cognitive ability and stunted growth. An infant’s diet must contain a proper balance of starch, minerals, vitamins, amino acids, and lipids. These essential nutrients can be administered through parenteral nutrition, which is expected to boost market growth. 

Increasing prevalence of chronic conditions such as cancer unswervingly impacts the use of parenteral nutrition across the country. Parenteral nutrition helps in the administration of vital nutrients that are useful in maintaining strength, energy, and hydration level amongst patients throughout the treatment regime. 

Nutrient Type Insights

Single-dose amino acid solutions held a substantial share in 2016. The increased usage of amino acid solutions can be attributed to an increase in the influx of regulatory approved solutions. Moreover, newly available amino acid solutions result in lesser adverse effects, thus enhancing care delivery. 

Carbohydrates followed the single-dose amino acids segment in terms of market share in 2016. Also, intravenous lipid emulsions are projected to witness lucrative growth over the forecast period. Lipid emulsion parenteral formulation showcase promising results, reducing complications such as skin irritation, thrombophlebitis, and pain. 

Dosage Form Insights

Parenteral nutrition can be supplied in various dosage forms, such as vials, ampoules, glass bottles, and bags. Bags are further sub-segmented into multi-chambered bags and others. Bags dominated the Middle East parenteral nutrition market with more than a 67.0% share in 2016. Bags are easy to handle, lightweight, and cost-efficient. Moreover, bags are also easy to dispose of after the administration of nutrient to the patient. 

These bags can be single, dual, or triple-chambered. Although single-chambered bags are abundant in the market, vials are anticipated to gain substantial share over the forecast period. Vials are often used for smaller concentration doses and they are used in hospital compounding. Increasing focus on customized treatment is likely to boost the usage of vials.

MEA parenteral nutrition market, by dosage form, 2016 (%)

Regional Insights

Saudi Arabia held a significant share of around 13.4% in 2016 due to the presence of the largest health care network and hospitals. Countries such as Kuwait, Oman, Lebanon, and Jordan are anticipated to gain remunerative share over the forecast period. Supportive government initiatives, an increasing number of healthcare settings, raising awareness, and increasing healthcare expenditure are likely to support their growth in the coming eight to nine years. The Health system in Qatar has improved in the past decade as a result of significant supportive investments by the government. The rate of child mortality has declined over the past couple of decades. 

Qatar spent USD 4.7 billion on healthcare in 2014, which was the highest in the Middle East. Kuwait is anticipated to witness lucrative growth over the forecast period owing to supportive government initiatives for the expansion of health resources. Approximately 80% of the investment in the healthcare sector of Kuwait is made by the government. Kuwait has one of the most modern healthcare infrastructures in the region with adequate clinics, health centers, & hospitals backed by skilled healthcare staff equipped to provide safe & effective healthcare. 

Competitive Insights

Key players of this market are B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Hospira Inc.; Qatar Pharma Factory; Pharmaceutical Solutions Industry; Kuwait Saudi Pharmaceutical Industries Co.; Alfa Laboratories; and Well Pharma. These companies are actively involved in improving their current product portfolio of parenteral nutrition to sustain their position in the market. Also, new drug development and their entry into untapped territories are expected to boost growth. 

For instance, in 2015, B. Braun Melsungen AG invested around USD 1.1 Billion in R&D of new products and expansion of production capacities. For instance, it is constructing a new manufacturing unit in Melsungen for the production of individual nutritional solutions. This investment is expected to help the company increase its goodwill.

MEA Parenteral Nutrition Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For this study, Grand View Research has segmented the MEA parenteral nutrition market based on the type of nutrients, dosage form, and region:

• Nutrient Type Outlook (Revenue, USD Million; 2014 - 2025)

  • Carbohydrate

  • Parenteral Lipid Emulsions

  • Single Dose Amino Acid Solutions

  • Trace Elements

  • Vitamins and Minerals

• Dosage Form Outlook (Revenue, USD Million; 2014 - 2025)

  • Vials

  • Ampoules

  • Bottles

  • Bags

    • Multi-chambered bags

    • Other bags

• Regional Outlook (Revenue, USD Million; 2014 - 2025)

  • The Middle East and Africa

    • Saudi Arabia

    • Qatar

    • Kuwait

    • UAE

    • Oman

    • Egypt

    • Lebanon

    • Jordan